Status:
UNKNOWN
Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver Transplantation
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Liver Transplantation
Hepatitis B
Eligibility:
All Genders
Phase:
NA
Brief Summary
Aim/Background: This study aims to investigate the necessity and efficacy of a hepatitis B virus (HBV) vaccine booster in children after liver transplantation. A universal mass vaccination program of ...
Detailed Description
The anti-HBs titer will be checked in the patients who received liver transplantation for \> 1 year. If the titer is \< 10 IU/L, a booster dose will be administered. The humoral (anti-HBs) and cellula...
Eligibility Criteria
Inclusion
- Children who received liver transplantation \> 1 year ago
Exclusion
- Are now in an unstable condition
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00147459
Start Date
September 1 2005
End Date
December 1 2012
Last Update
December 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan